Category: COVID-19

Second-Dose Appointments Now Open

Posted on by Kate Smith

Individuals who received their first dose of COVID-19 28 or more days ago (on or before January 29) from a pharmacy, medical provider, clinic or other source in Delaware and have not yet obtained a second dose may sign up for a Friday appointment at the ongoing vaccination event at Dover International Speedway operated by the State of Delaware and Federal Emergency Management Agency. Those in the new eligibility window should make their appointments for Friday, before 6 p.m. Thursday. This is a wider eligibility window than announced earlier this week. Those being vaccinated will need to demonstrate with their Read More …

DPH: Updated Plans for 2nd Dose

Posted on by Kate Smith

DOVER (Jan. 28, 2021) – Today, the Division of Public Health (DPH) announced an updated approach to administering second doses in response to new guidance from the Centers for Disease Control (CDC). The CDC announced Friday that an interval of 42 days between doses is acceptable, if adhering to the 21-day (Pfizer) and 28-day (Moderna) intervals is not possible. Given extremely limited vaccine supply, DPH is recommending to vaccine partners that they schedule second doses between 28 and 35 days after the first dose is administered. This policy will enable the state to continue administering first doses to the vulnerable Read More …

COVID-19 Vaccine Update

Posted on by Kate Smith

Delaware Division of Public Health | January 26, 2021 With limited supply of vaccine from the federal government, the state is faced with very difficult decisions about the most effective use of the doses it has. The science shows that the first dose of COVID-19 vaccine provides 52% to 80% protection, so concentrating on first doses is critical to reducing hospitalizations and deaths. We also believe we need to get Phase 1A high-risk health care workers second doses as soon as possible – both because they have frequent contact with COVID patients and have less ability to social distance. Until Read More …

Risk related to spread of new SARS-CoV-2 variants of concern in the EU/EAA

Posted on by Kate Smith

This risk assessment presents the latest available information on the recent emergence of two variants of potential concern, VOC 202012/01 discovered in the United Kingdom (UK) and another variant, 501.V2 identified in South Africa. It also assesses the risk of these variants of concern being introduced and spread in the EU/EEA, as well as the increased impact this would have on health systems in the coming weeks. Read more.